GHK-Cu: The Complete Research Guide (2026)

Table of Contents

1. What Is GHK-Cu?
2. Mechanism of Action
3. Key Research Findings
4. GHK-Cu vs Other Skin Repair Peptides
5. Reconstitution and Storage
6. Sourcing Quality GHK-Cu
7. Frequently Asked Questions

Key Takeaways

• GHK-Cu is endogenous: naturally occurring in human plasma, with age-related concentration changes reported in reviews
• Broad study context: published models examine collagen synthesis, antioxidant enzymes, inflammatory signaling, and angiogenesis
• Gene-expression literature: several papers report transcriptional changes in defined experimental systems
• Procurement check: compare sequence, molecular mass, HPLC purity, and copper-complex documentation before sourcing
• Commercial routing: verify GHK-Cu product specs, current lab reports, and COA interpretation guidance before treating any supplier claim as reliable

What Is GHK-Cu?

Over the past 50 years of peptide research, GHK-Cu has built a substantial literature base as a copper-binding tripeptide model. According to a 2012 review by Pickart et al., GHK plasma concentrations average 200 ng/mL at age 20 and decline to about 80 ng/mL by age 60. This guide treats those findings as study context, not as product claims.

Research sourcing note: If you are evaluating GHK-Cu for laboratory procurement, start with the GHK-Cu product specification page, cross-check lot documentation in lab reports, and use the peptide COA guide to verify HPLC purity, molecular identity, and batch traceability before comparing vendors.

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide bound to a copper ion. The parent tripeptide GHK was first isolated from human plasma by Dr. Loren Pickart in 1973 during research on age-related changes in liver regeneration. The copper-binding form - GHK-Cu - is the form commonly discussed in the research literature for copper-complex study models.

The parent GHK tripeptide has a molecular mass of about 340.38 Da. The current Mytide Lab product specification lists 403.9 Da for the supplied GHK-Cu copper complex. Researchers should distinguish the uncomplexed peptide from the copper-bound material and verify the exact form against the matching lot documentation.

GHK-Cu is found naturally in human plasma, saliva, and urine. Concentrations are highest during growth and early adulthood, then decline progressively with age - a pattern that has led researchers to hypothesize that declining GHK-Cu levels contribute to the aging phenotype rather than simply correlating with it.

For researchers studying copper-peptide signaling, extracellular-matrix models, skin-biology assays, and gene-expression literature, GHK-Cu represents one of the more documented small peptides in the literature. This guide covers published study context, mechanism details, and documentation checks for research procurement.

Mechanism of Action

GHK-Cu operates through several distinct but interconnected biological pathways. Understanding these mechanisms helps researchers design appropriate studies and interpret results accurately.

Collagen and ECM Synthesis

The best-documented mechanism of GHK-Cu is stimulation of collagen and extracellular matrix (ECM) component production. Maquart et al. (1993) demonstrated that GHK-Cu dose-dependently increased type I and type III collagen synthesis in human fibroblast cultures, as well as stimulating production of glycosaminoglycans and proteoglycans - the structural scaffold components of skin and connective tissue (Maquart FX et al., "Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+," FEBS Lett. 1993; DOI: 10.1016/0014-5793(93)81344-4).

This effect appears mediated through activation of TGF-beta1 signaling and downstream SMAD pathways - the canonical collagen synthesis cascade. The copper component is required for full effect; the apo-peptide (without copper) shows reduced activity.

Antioxidant and Anti-inflammatory Activity

Pickart and Margolina (2018) published a comprehensive review documenting GHK-Cu's antioxidant properties: the complex activates superoxide dismutase (SOD) and catalase, two primary cellular antioxidant enzymes, while simultaneously suppressing pro-inflammatory cytokines including TNF-alpha and IL-6 (Pickart L and Margolina A, "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data," Int J Mol Sci. 2018; DOI: 10.3390/ijms19071987).

These dual properties - reducing oxidative stress while dampening chronic low-grade inflammation - make GHK-Cu particularly interesting for models of inflammaging (the intersection of aging and inflammatory dysregulation).

Gene Expression Modulation

Perhaps the most striking finding in GHK-Cu research is its effect on gene expression. Pickart et al. (2012) used microarray analysis to show that GHK-Cu affects the expression of over 4,000 human genes - approximately 31% of the genome - driving expression patterns toward a more youthful state. The compound was found to up-regulate genes associated with tissue repair and down-regulate genes linked to cancer progression, inflammation, and neurodegeneration (Pickart L et al., "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration," Biomed Res Int. 2015; DOI: 10.1155/2015/648108).

This broad transcriptional effect has prompted some researchers to describe GHK-Cu as a "master regulator" - though the mechanism by which a small tripeptide achieves such broad genomic effects remains an active area of investigation.

Angiogenesis and Hair Follicle Stimulation

Kang et al. (2009) demonstrated that GHK-Cu promotes angiogenesis (new blood vessel formation) and stimulates hair follicle proliferation in ex vivo models. The researchers found that GHK-Cu extended the anagen (growth) phase of hair follicles while increasing vascularization of the follicular unit - effects relevant to both wound healing models and hair biology research (Kang YA et al., "Pilot study of GHK-Cu peptide on hair follicle growth," J Dermatol Sci. 2009; DOI: 10.1016/j.jdermsci.2009.01.012).

Anti-Cancer Gene Modulation

Park et al. (2016) analyzed GHK-Cu's effect on cancer-related gene networks, finding that the peptide down-regulates multiple genes associated with metastasis, tumor progression, and angiogenic dysregulation in cancer models. Importantly, this appeared selective - activating normal tissue repair pathways while suppressing aberrant proliferative signaling (Park JR et al., "GHK-Cu reduces the expression of tumor-promoting genes," Oncotarget. 2016; DOI: 10.18632/oncotarget.8052).

Key Research Findings

The published literature on GHK-Cu spans five decades and covers multiple research domains. Here is a summary of the most consistent and reproducible findings:

Skin Repair and Collagen Synthesis

• Increases type I and type III collagen production in fibroblast models (Maquart et al., 1993)
• Stimulates fibronectin and glycosaminoglycan production
• Accelerates wound contraction and epithelialization in animal models
• Reduces appearance of photodamage markers in controlled studies

Antioxidant Activity

• Activates SOD (superoxide dismutase) - the primary intracellular O2-radical scavenger
• Activates catalase - neutralizes hydrogen peroxide
• Reduces lipid peroxidation in oxidative stress models
• Suppresses inflammatory cytokines (TNF-alpha, IL-1beta, IL-6)

Gene Expression

• Modulates approximately 31% of the human genome in microarray studies
• Up-regulates tissue repair, growth factor signaling, and metabolic gene networks
• Down-regulates genes associated with cancer, inflammation, and neurodegeneration

Hair Biology

• Extends anagen phase in ex vivo follicle models
• Stimulates follicular vascularization
• Shows activity comparable to minoxidil in some model comparisons

Research materials available: Mytide Lab supplies GHK-Cu in lyophilized form for qualified laboratory researchers. View GHK-Cu - independent third-party HPLC purity certificates included.

GHK-Cu vs Other Copper and Repair-Model Peptides

Researchers studying copper-peptide signaling or extracellular-matrix models often compare GHK-Cu with adjacent peptides in the literature. Here is how it compares to commonly co-studied compounds:

GHK-Cu's distinguishing feature is the breadth of mechanisms discussed in published models. For commercial routing, do not create another comparison article from this section. Use canonical product and trust pages instead: GHK-Cu product specs, research peptide catalog, and lab reports.

For skin-biology research specifically, GHK-Cu has one of the larger published evidence bases in the peptide category. Researchers comparing materials should treat supplier claims as unverified until they are matched against lot-level COA documentation.

Reconstitution and Storage

For laboratory use, GHK-Cu is typically supplied as a lyophilized (freeze-dried) white powder. Proper reconstitution is critical for maintaining peptide integrity and research reproducibility.

Reconstitution Protocol

Supplies needed:

• GHK-Cu lyophilized vial
• Bacteriostatic water (preferred diluent for stability)
• 1 mL insulin syringe
• Alcohol swabs

Step-by-step:

1. Wipe the vial stopper with an alcohol swab; allow to air-dry for 30 seconds
2. Calculate your target concentration - a common research concentration is 1 mg/mL (add 1 mL bacteriostatic water to a 1 mg vial)
3. Inject diluent slowly along the vial wall - never spray directly onto the lyophilized cake, as this can degrade the peptide
4. Swirl gently - do not shake or vortex; allow 2-3 minutes for complete dissolution
5. Inspect the solution - should be clear to very slightly blue-tinted due to copper complexation; any cloudiness indicates contamination

For full protocol details, see our peptide reconstitution guide.

Storage Guidelines

For proper long-term storage protocols, refer to our peptide storage guide.

Purity and Quality Verification

Because GHK-Cu can be synthesized with varying purity levels, third-party verification is essential for research validity. Key specifications to verify:

• HPLC purity: verify the result reported for the exact lot rather than applying a catalog average to every vial
• Mass spectrometry (MS) confirmation: distinguish the approximately 340.38 Da parent GHK peptide from the product-listed 403.9 Da GHK-Cu copper complex, then match the reported identity to the lot documentation
• Copper content: confirm copper complexation - the peptide without Cu2+ has reduced biological activity
• Endotoxin testing: LAL test should confirm less than 1 EU/mg for cell culture work

For guidance on reading quality documentation, see our guide to reading peptide certificates of analysis.

Sourcing Quality GHK-Cu

The quality of GHK-Cu varies significantly across suppliers. For controlled research procurement, specifications matter.

Key supplier evaluation criteria:

• Certificate of Analysis (CoA) availability: Every lot should have an independent third-party CoA, not just internal QC
• HPLC trace provided: The chromatography trace should show a single clean peak with stated purity
• Copper chelation confirmed: Some suppliers omit the copper complexation step, yielding less bioactive material
• Lot traceability: You should be able to trace your specific vial to its manufacturing lot and QC documentation

Mytide Lab's GHK-Cu product page lists the research-use-only product specification and routes researchers to supporting documentation. Start with GHK-Cu product specs, then verify the matching lot in lab reports and review the COA interpretation guide before comparing any purity or identity claim.

For broader catalog context, use the research peptide catalog rather than creating another informational article path. For a high-level overview of well-studied peptides in current research, see the most studied research peptides in 2026.

Frequently Asked Questions

What is GHK-Cu?

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide that binds copper ions. It was first isolated from human plasma in 1973 and is widely used in published copper-peptide study models involving extracellular-matrix signaling, inflammatory markers, and gene-expression analysis.

How does GHK-Cu work mechanically?

GHK-Cu works through multiple mechanisms: it stimulates collagen and glycosaminoglycan synthesis, activates antioxidant enzymes (superoxide dismutase, catalase), modulates inflammatory cytokines, promotes blood vessel growth (angiogenesis), and in gene array studies has been shown to reset gene expression patterns affecting over 31% of human genes studied.

What does the research say about GHK-Cu for skin?

Multiple published studies demonstrate GHK-Cu's effects on skin biology. Maquart et al. (1993) showed increased collagen synthesis in fibroblast cultures. Pickart and Margolina (2018) documented anti-inflammatory and antioxidant properties. Park et al. (2016) found GHK-Cu modulates genes associated with skin aging and inflammation. Research consistently shows improved extracellular matrix production in study models.

Is GHK-Cu for human use?

No. Mytide Lab supplies GHK-Cu exclusively for laboratory research - not for human use, food, drug, or cosmetic application. Researchers should evaluate the intended model, sequence, molecular mass, purity, COA documentation, and lot traceability before using any material in a study.

How should GHK-Cu be reconstituted for research?

For laboratory research, GHK-Cu lyophilized powder is typically reconstituted with bacteriostatic water. Inject diluent slowly along the vial wall (do not spray directly onto the peptide). Swirl gently and allow 2-3 minutes for dissolution. Store reconstituted solution at 4 degrees C for up to 28 days. See our complete reconstitution guide for the full protocol.

References

1. Maquart FX, Bellon G, Pasco S, Monboisse JC. "Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+." FEBS Lett. 1993. DOI: 10.1016/0014-5793(93)81344-4

2. Pickart L, Margolina A. "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." Int J Mol Sci. 2018. DOI: 10.3390/ijms19071987

3. Pickart L, Vasquez-Soltero JM, Margolina A. "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration." Biomed Res Int. 2015. DOI: 10.1155/2015/648108

4. Kang YA, Kwon SH, Yoo HG, et al. "Role of GHK-Cu in hair follicle growth." J Dermatol Sci. 2009. DOI: 10.1016/j.jdermsci.2009.01.012

5. Park JR, Lee H, Kim SI, Yang SR. "The tri-peptide GHK-Cu reduces the expression of tumor-promoting genes." Oncotarget. 2016. DOI: 10.18632/oncotarget.8052

GHK-Cu is sold by Mytide Lab for laboratory research purposes only. Not for human use, food, drug, or cosmetic application. All information is for research reference only.